S100B and melanoma: In our previous study, we found that pT4b primary tumor category, M1c stage or M1d stage at the start of therapy, elevated baseline serum S100B level, and elevated LDH level were associated with poor survival in patients with stage IV melanoma treated with anti-PD-1 [20].